Compare Eli Lilly And Co (LLY) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Trip.com Group Ltd — how do they compare? Eli Lilly And Co trades at $1,147.06 (market cap $1.02T), while Trip.com Group Ltd trades at $44.26 (market cap $28.12B). The key difference: Eli Lilly And Co is far larger — about 36.3× Trip.com Group Ltd's market cap, and Eli Lilly And Co pays the higher dividend (0.6%). Which is the better fit depends on your goals.
| LLY | TCOM | |
|---|---|---|
Market Cap | $1.02T | $28.12B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.24K | $78.96 |
52-Week Low | $625.65 | $39.84 |
Enterprise Value | $1.06T | $20.82B |
Dividend Yield | 0.6% | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
